Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo
NCT03608917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2021-03-11
Summary
1. Total Glucosides of Paeony(TGP) As a traditional Chinese medicine, peony root is the dried root of peony of Ranunculaceae, cultivated all over the country.The main ingredient is a group of glycosides, including paeoniflorin, hydroxy paeoniflorin, paeoniflorin, paeoniflorin, benzoyl paeoniflorin etc, collectively referred to as total glucosides of paeony(TGP). Paeoniflorin accounted for more than 90% of the TGP, is the main active ingredient of white peony root.By pharmacological and clinical studies of TGP, it have found that the mechanism of TGP is unique and mainly acts on the upstream of the immune response - inhibiting the presentation of antigens. It is different from immunosuppressive agents on T, B lymphocytes, or hormones and other drugs acting on the whole process.
2. Vitiligo Vitiligo is a pigment deprived skin disease caused by the destruction of melanocytes, the global incidence of about 1%. The pathogenesis is not yet clear, the current study shows that oxidative stress and autoimmunity is an important part of its occurrence and development.
3. The basic and clinical research of TGP used in vitiligo The ratio of cluster of differentiation 4+ / cluster designation 8+ T cell vs. cluster of differentiation 4+ chronotropic dose 25+ in the peripheral blood of patients with vitiligo could be significantly increase, after patients treatment by TGP combined with tacrolimus. Thereby enhancing the patient's maintenance of immune self-stability and Immune tolerance ability, promoting the healing of skin lesions. It showed significant effect in stable vitiligo,when patients treated by autologous epidermal grafting combined with TGP.
Conditions
- Vitiligo
Interventions
- DRUG
-
Total Glucosides of Paeony(TGP)
Total Glucosides of Paeony(TGP) as a traditional Chinese medicine, peony root is the dried root of peony of Ranunculaceae, cultivated all over the country.TGP is new drug of western medicine, original discovered by Professor Xu who is a famous pharmacologist. The main ingredient is a group of glycosides, including paeoniflorin, hydroxy paeoniflorin, paeoniflorin, paeoniflorin, benzoyl paeoniflorin etc, collectively referred to as total glucosides of paeony(TGP)
- DEVICE
-
Narrow band-ultraviolet b(NB-UVB)
phototherapy on treating vitiligo
- DRUG
-
Total Glucosides of Paeony(TGP) analogue
Total Glucosides of Paeony(TGP) analogue as a placebo for Control group
Sponsors & Collaborators
-
Air Force General Hospital of the PLA
collaborator OTHER_GOV -
First Hospital of China Medical University
collaborator OTHER -
Chinese Academy of Medical Sciences
collaborator OTHER -
xjpfW
lead OTHER
Principal Investigators
-
Tianwen Gao, Prof · Dermatology Derpartment of Xijing Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-17
- Primary Completion
- 2019-04-30
- Completion
- 2019-07-31
Countries
- China
Study Locations
More Related Trials
-
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241 ·Status: COMPLETED ·Phase: NA
-
The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients
NCT03718962 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo
NCT05247489 ·Status: COMPLETED ·Phase: PHASE2
-
Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo
NCT03487042 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo
NCT02506101 ·Status: TERMINATED ·Phase: NA
-
Evaluation of AMG 714 for Vitiligo
NCT04338581 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
NCT05238077 ·Status: TERMINATED ·Phase: NA
-
Improved Phototherapy in Patients With Vitiligo
NCT05836441 ·Status: UNKNOWN ·Phase: NA
-
A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects
NCT03715829 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study
NCT06370650 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT00367224 ·Status: COMPLETED ·Phase: NA
-
Photocil (Topical) for the Treatment of Vitiligo
NCT01992185 ·Status: COMPLETED ·Phase: NA
-
To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study
NCT03864315 ·Status: COMPLETED ·Phase: NA
-
NB-UVB and PUVA Vitiligo Study
NCT01732965 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
NCT06991972 ·Status: RECRUITING ·Phase: PHASE4
-
Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo
NCT06394349 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo
NCT03199664 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma
NCT03155698 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Red Light in Vitiligo
NCT01787708 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo
NCT04811131 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
NCT07152626 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters
NCT05256147 ·Status: TERMINATED ·Phase: NA
-
Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.
NCT05316987 ·Status: COMPLETED ·Phase: NA
-
Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
NCT00217009 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo
NCT03158675 ·Status: UNKNOWN ·Phase: NA